Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling egfr'

Search results for: 'research area jak stat signaling egfr'

Items 31-40 of 40

Page
per page
  1. PD153035 hydrochloride
    A8199 PD153035 hydrochloride
     1 Citation
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥3.97 mg/mL
  2. Erlotinib
    A3397 Erlotinib
     4 Citation
    Summary: EGFR tyrosine kinase inhibitor
      insoluble in H2O; ≥19.65 mg/mL
  3. BMS-690514
    A3256 BMS-690514
    Summary: HER/EGFR inhibitor
      Soluble in DMSO
  4. AZD3759
    B5962 AZD3759
    Summary: EGFR inhibitor，oral active
      ≥23 mg/mL
  5. AST-1306
    A8367 AST-1306
    Summary: EGFR/HER2 inhibitor
      ≥22.45 mg/mL
  6. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    Target: EGFR|ErbB
    Summary: ErbB inhibitor
      ≥23.7 mg/mL
  7. ARRY-380
    A8366 ARRY-380
    Target: HER2
    Summary: Tyrosine kinase HER2 and p95-HER2 inhibitor
      ≥28.5 mg/mL
  8. AZD-9291 mesylate
    B1105 AZD-9291 mesylate
    Summary: third generation EGFRm inhibitor, oral and irreversible
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  9. RG 13022
    B6115 RG 13022
    Summary: EGFR tyrosine kinase inhibitor
      ≥26.6 mg/mL
  10. Varlitinib (ARRY334543)
    A8365 Varlitinib (ARRY334543)
    Summary: ErbB inhibitor
      ≥23.35 mg/mL

Items 31-40 of 40

Page
per page